Biopharmaceutical third-party logistics market growth outlook through 2030
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Forecasted Market Size Trajectory Of The Biopharmaceutical Third-Party Logistics Market From 2026 To 2030?
Recent years have witnessed substantial growth in the biopharmaceutical third-party logistics market. It is projected to expand from $150.5 billion in 2025 to $161.71 billion in 2026, at a compound annual growth rate (CAGR) of 7.4%. This historic growth has been fueled by an increase in biologics and vaccine production, the rising trend of pharmaceutical companies outsourcing logistics services, the expansion of global biopharmaceutical supply chains, more stringent regulatory requirements for drug transportation, and the limited in-house logistics capabilities of biopharma firms.
The biopharmaceutical third-party logistics market is projected to experience substantial expansion in the coming years, reaching a size of $221.15 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.1%. This expansion during the forecast period is driven by factors such as the surging demand for personalized medicines, the broadening distribution of cell and gene therapies, increased investments in intelligent logistics platforms, a heightened emphasis on comprehensive supply chain transparency, and the rise in international biopharmaceutical commerce. Key developments anticipated within this timeframe involve the greater integration of sophisticated cold chain logistics solutions, an escalating need for transportation services that monitor temperature, wider deployment of real-time shipment tracking systems, the growth of specialized biopharma warehousing facilities, and a sharpened focus on logistics operations adhering to regulations.
Access Your Free Sample Report For In-Depth Market Analysis:
What Key Drivers Are Fueling The Growth Of The Biopharmaceutical Third-Party Logistics Market?
The increasing inclination towards outsourcing logistics is anticipated to fuel expansion in the biopharmaceutical third-party logistics market. This practice, outsourcing logistics, entails contracting an external entity to manage either all or a segment of a firm’s logistical operations. Within biopharmaceutical third-party logistics, outsourcing logistics finds application in delegating cryogenic supply chain management to specialized logistics partners. As an illustration, data from February 2024, provided by the Bureau of Transportation Statistics, a US-based division of the Department of Transportation (DOT), indicated that for-hire freight shipments saw an increase of 1.8% in December 2023 when juxtaposed with December 2022, concurrently, the Freight Transportation Services Index climbed from 136.6 in December 2022 to 139.1 in December 2023. Consequently, the expanding practice of outsourcing logistics is projected to invigorate the expansion of the biopharmaceutical third-party logistics market.
Which Segment Classifications Are Used In The Biopharmaceutical Third-Party Logistics Market Segment Analysis?
The biopharmaceutical third-party logistics market covered in this report is segmented –
1) By Supply Chain: Cold Chain, Non-Cold Chain
2) By Service: Transportation, Warehousing And Storage, Other Services
3) By End-User: Pharmaceutical And Biopharmaceutical Companies, Medical Device Companies, Hospitals And Clinics, Other End-Users
Subsegments:
1) By Cold Chain: Refrigerated Transport, Temperature-Controlled Storage, Specialized Packaging
2) By Non-Cold Chain: Ambient Transport, Standard Storage Solutions, General Packaging Methods
What Trends Are Influencing The Biopharmaceutical Third-Party Logistics Market?
Leading firms within the biopharmaceutical third-party logistics market are prioritizing strategic initiatives like business expansion in life sciences and healthcare logistics to improve logistical prowess concerning pharmaceutical and healthcare products, thereby ensuring efficient storage and distribution. Business expansion in life sciences and healthcare logistics involves the calculated development by logistics providers to boost their proficiency in moving and overseeing medical products, which is vital for guaranteeing prompt arrival and preserving the condition of temperature-sensitive items essential for patient care. As an illustration, in May 2025, DHL Group, a Germany-based logistics company, unveiled its revamped Life Sciences & Healthcare (LSH) campus in Florstadt, Germany. This modern site features ultra cold storage zones (down to –70°C), real-time visibility systems, and GDP certified infrastructure, facilitating the safe management of temperature-sensitive biopharmaceuticals, such as mRNA vaccines, clinical trial materials, and advanced therapies.
Which Firms Are Contributing To The Biopharmaceutical Third-Party Logistics Market Ecosystem?
Major companies operating in the biopharmaceutical third-party logistics market are McKesson Corporation, AmerisourceBergen Corporation, United Parcel Service of America Inc., FedEx Corporation, DHL International GmbH, Kuehne + Nagel International AG, SF Express Co Ltd., DB Schenker, CH Robinson Worldwide Inc., Nippon Express Group, Expeditors International of Washington Inc., Sinotrans Limited, XPO Logistics Inc., Kerry Logistics Network Limited, Bollore Logistics, VersaCold Logistics Services, Cryoport Inc., Agility Logistics Corp, Fisher Clinical Services, CEVA Logistics Inc., LifeScience Logistics, Cold Chain Technologies LLC, Langham Logistics, Airpharm Logistics, Express Courier International, Bio Pharma Logistics
Get The Full Biopharmaceutical Third-Party Logistics Market Report:
Which Region Accounts For The Largest Portion Of The Biopharmaceutical Third-Party Logistics Market?
North America was the largest region in the biopharmaceutical third party logistics market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical third-party logistics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Biopharmaceutical Third-Party Logistics Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Biopharmaceutical Third-Party Logistics Market 2026, By The Business Research Company
Third Party Logistics 3Pl Market 2026
https://www.thebusinessresearchcompany.com/report/third-party-logistics-3pl-market
Biopharmaceutical Third Party Logistics Market Report 2026
Pharmaceutical Logistics Market Report 2026
https://www.thebusinessresearchcompany.com/report/pharmaceutical-logistics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
